Asters - General Sponsor of UKRPHARMA 2010
UKRPHARMA 2010: All-Ukrainian Pharmaceutical Forum
2-3 June 2010
InterContinental Kiev (Kyiv, 2A Velyka Zhytomyrska Street)
As a General Sponsor of the event Asters is delighted to invite you to UKRPHARMA 2010: All-Ukrainian Pharmaceutical Forum to be held on 2-3 June 2010 at the InterContinental Hotel in Kiev. The two-day event will bring together the pharmaceutical business elite, key government officials and legal practitioners to discuss the most pressing issues of the Ukrainian pharmaceutical market, seek solutions to current challenges and explore new opportunities.
Key speakers include:
Ala Ciobanu, General Manager, Roche Ukraine
Jean-Paul Shoer, Regional Director, Group of companies Sanofi-Aventis and Zentiva
Andrei Stogniy, General Director, GlaxoSmithKline Pharmaceuticals Ukraine
Igor Svechkar, Asters
Oleksandr Gudzenko, Deputy Minister of Health Protection of Ukraine
Oleksandr Melnychenko, First Deputy Head, Ukrainian Antimonopoly Committee
Valeriy Pyatnitskiy, Deputy Minister of Economy of Ukraine
Tetyana Bakhteyeva, Chairman, Committee on Health Protection Issues, Parliament of Ukraine
Borys Snizhko, Asters
Volodymyr Dudka, President, Association of Pharmaceutical Distributors PharmUkraine
Yuriy Krestinskiy, Director, Institute for Public Health Protection Problems, Russia
Olga Baula, First Deputy Director, State Pharmacological Centre, Health Ministry of Ukraine
Oksana Kondratieva, Head, Department of Unfair Competition Investigations, Ukrainian Antimonopoly Committee
The challenging issues to be discussed include:
Prospects of legislative changes in the Ukrainian pharmaceutical sector
Professional pharmaceutical associations: experience, possibilities and advantages of self-regulation
Pricing and reimbursement – in search for optimal ways to increase the accessibility of medicine
Competition matters: AMC activity in pharmaceutical sector in 2009 and prospects for 2010, concentrations, antidumping, unfair competition
State quality control
Promotions and advertisements: peculiarities, problems and perspectives
Regulatory problems with clinic trials in Ukraine and the ways to overcome them
IP protection matters: patent, trademarks, etc.
Post-crisis pharmaceutical M&A
… and many more.
Please see the brochure for more details.
Click here to register.